In this video, Josh Helman, MD discusses the pathogenic mechanisms of the pro-inflammatory immune protein galectin-3 and its role in neurodegenerative diseases, biofilm formation, autoimmunity and other critical conditions. An expert in the fast-growing field of galectin-3 research, Dr. Helman shares key research findings, as well as clinical pearls on the application of a galectin-3 serum assay. He also discusses the use of different galectin-3 inhibitors—from drug therapies currently in clinical trials to extensively researched nutraceutical agents—as novel therapeutic adjuncts for Alzheimer’s disease and other galectin-3-mediated conditions.
RELATED ARTICLES:
Blocking Galectin-3: A Powerful Strategy for Neurodegeneration and Chronic Disease
